Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Birgitta Stegmayr
Department
of Public Health and Clinical Medicine, Umeå University Hospital,
Umeå, S-901 85, Sweden Correspondence to: B Stegmayr birgitta.stegmayr{at}medicin.umu.se
Education and debate p 648
With recent advances in molecular genetics, there has been
a surge in interest in using stored blood samples for genetic research, even though informed consent at the time of blood sampling did not
include this possibility. One of the cornerstones of the World Medical
Association's Declaration of Helsinki on ethical principles for
medical research is the need for informed consent and the right of any
participant in a research project to withdraw at any
time.1 We report here our experiences of seeking informed consent for academic and commercial genetic research on blood samples
collected more than a decade earlier.
A total of 1583 out of 2000 (79.2%) randomly selected men
and women in the age group 25-64 years participated in the 1990 risk
factor survey in the World Health Organization's MONICA
project.
2 3
Participants were given written information
and asked to donate blood for "future research on cardiovascular
disorders and diabetes." A total of 1494 blood samples were taken (in
89 participants, consent was not given or technical problems arose in
obtaining a blood sample). The blood samples were fractionated and
stored at -80° C.
In 2001, 11 years later, 85 of the 1494 individuals had died, moved
abroad, or had an unknown address (figure). We sent a letter to the
remaining 1409 participants with information about ongoing genetic
studies and seeking consent at three different levels (figure). Of the
1409 subjects, 1342 (95.2%) responded.
![]()
Methods and results
Top
Methods and results
Comment
References

View larger version (32K):
[in a new window]
Follow up in 2001 of participants in 1990 MONICA survey, showing
numbers of participants lost to follow up and responses to
questionnaire about consent for blood to be used in genetic research
A total of 1311 out of 1409 (93.0%) eligible participants gave their consent for their blood samples to be used for academic genetic research, provided that the ethics committee had approved the research. Thirty one (2.2%) participants did not give their consent; 64 participants did not reply and three provided incomplete answers (4.8% together).
Of the 1311 participants who gave their consent, 292 (22.3%)
wanted to be informed about, and give new consent for, each new genetic
project (figure). The rest gave general consent to genetic research, as
long as an ethics committee had approved the research. However, a
further 35 (2.5%) participants did not give consent for their blood to
be used for industrial genetic research (figure).
| |
Comment |
|---|
|
|
|---|
Eleven years after donation of samples, only a very small proportion of participants did not give consent for their blood to be used in academic or industrial genetic research.
To our knowledge, this report is the first to provide empirical
data from a "real life" situation
that is, people's willingness to give consent to genetic research on their own blood donated more
than a decade previously, when genetic research was not an issue.
Participation in risk factor screening is, in itself, an expression of
willingness to contribute to research. The participants in the original
survey in 1990 were randomly selected, with a participation rate as
high as 79%, thus suggesting that our results are representative. The
MONICA project is well known and well regarded among the people in this
part of Sweden, where it has been running since 1985, and the great
willingness to give consent to genetic research emphasises the
importance of close researcher-participant interaction.
We conclude that (a) it is feasible to obtain
individual consent for genetic research many years after blood was
donated; (b) people's readiness to contribute to genetic
research is high, at least in the framework of a carefully conducted
study that is well known to the population; and (c) consent
is given nearly as often for industrial genetic research as for
academic genetic research, provided that the blood samples are
anonymised and an ethics committee has approved the research.
| |
Acknowledgments |
|---|
Contributors: BS was responsible for data entry, management, and analyses. She acts as guarantor for the paper. KA has guided the analyses. Both authors contributed equally to writing the manuscript
| |
Footnotes |
|---|
Funding: Swedish Foundation for Strategic Research, the Swedish Research Council, the Swedish Heart and Lung Foundation, and the Swedish Stroke Foundation.
Competing interests: None declared.
| |
References |
|---|
|
|
|---|
| 1. |
World Medical Association.
Declaration of Helsinki: ethical principles for medical research involving human subjects.
JAMA
2000;
284:
3043-3045 |
| 2. | Huhtasaari F, Asplund K, Stegmayr B, Lundberg V, Wester PO. Trends in cardiovascular risk factors in the northern Sweden MONICA study. Who are the winners? Cardiovasc Risk Factors 1993; 3: 215-221. |
| 3. | Tunstall-Pedoe H. The World Health Organization MONICA project (monitoring of trends and determinants in cardiovascular diseases): a major international collaboration. J Clin Epidemiol 1988; 41: 105-114[CrossRef][Web of Science][Medline]. |
(Accepted 4 April 2002)
Read all Rapid Responses